Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 12:39 pm Purchase |
2023-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 213,529 4.500% |
107,340 (+101.08%) |
Filing History |
| 2023-01-27 2:18 pm Unchanged |
2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 106,189 8.497% |
0 (Unchanged) |
Filing History |
| 2023-01-25 3:18 pm Purchase |
2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 106,189 8.497% |
106,189 (New Position) |
Filing History |
| 2022-01-12 10:07 am Purchase |
2021-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 4,194,140,000 8.840% |
1,100,574,000 (+35.58%) |
Filing History |
| 2021-01-22 5:27 pm Purchase |
2020-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 3,093,566,000 8.010% |
244,707,800 (+8.59%) |
Filing History |